Kymera presents preclinical IBD data for oral IRF5 degrader KT-579
Go back to Kymera presents preclinical IBD data for oral IRF5 degrader KT-579| (NASDAQ: KYMR) | Delayed: 96.89 -2.56 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.45 | 52 Week High | $ | |||
| Open | $97.77 | 52 Week Low | $ | |||
| Day High | $100.69 | P/E | N/A | |||
| Day Low | $94.62 | EPS | $ | |||
| Volume | 847,679 | |||||

